Premium
Promoting innovation and access to quality, safe, efficacious, and affordable medicines for children: A China approach on the 69 th World Health Assembly
Author(s) -
Zhang Lingli,
Li Bo,
Liu Zhanqiang,
Li Mengtao,
Zheng Hong,
Sun Yang
Publication year - 2017
Publication title -
journal of evidence‐based medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 22
ISSN - 1756-5391
DOI - 10.1111/jebm.12250
Subject(s) - china , promotion (chess) , access to medicines , quality (philosophy) , economic growth , business , medicine , political science , environmental health , developing country , economics , politics , philosophy , epistemology , law
This study is to provide reference for the proper understanding of the content of “Promoting Innovation and Access to Quality, Safe, Efficacious, and Affordable Medicines for Children” resolution of 69 th World Health Assembly (WHA), and facilitate the policy making and implication of the Resolution. Through descriptive analysis, the author introduce the proposal background and approving process of the resolution, and interpret the resolution content. The approval of “Promoting Innovation and Access to Quality, Safe, Efficacious, and Affordable Medicines for Children” at WHA represents China's international discourse right on improving the basic medical service among children, the most vulnerable population; highlights China's responsibility and magnitude of a great nation. It is an effective promotion for China's new medical reform and the implication of the Millennium Development Goals (MDGs), as well as a great contribution to the global health of children from China.